AzTrials
AzTrials

Healthy SubjectsNCT05635721

Influence of Different Ankle Positions on Nerve Conduction Parameters of Deep Peroneal Nerve

An observational study of Healthy Subjects, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

BACKGROUND: The deep peroneal nerve arises as a branch of the common peroneal nerve which courses around the neck of the fibula. The motor component of deep peroneal nerve is responsible for innervating the anterior compartment of the lower leg which includes the tibialis anterior, extensor hallucis longus, extensor… Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Subjects
How many people
31 participants
Where
1 siteEgypt
Study dates
5 Dec 2022to 26 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: 31 healthy subjects of both genders will be recruited to participate in this study

Who may be able to join

  • Healthy subjects.
  • Age ranges from 20 to 40 years because longer latencies and slower nerve conduction velocity are seen significantly with increasing age.
  • All participants will be selected with body mass index (BMI) between 18.5 and 24.9kg/cm2 .

Who cannot join

  • Elderly subjects.
  • Pregnant women.
  • Subjects with history of or risk factors for peripheral nerve lesions.
  • Obese subjects.
  • Subjects with any foot deformity.
  • History of lower limb fractures.
Show all 11Show fewer
  • History of surgery to lower limbs
  • Diabetic patients.
  • Patients with cardiovascular disorders.
  • Hypertensive patients.
  • Women wearing high heeled shoes.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Mahmoud Salah

    Aga, 055555

Other trials in Egypt

About this study

BACKGROUND:

The deep peroneal nerve arises as a branch of the common peroneal nerve which courses around the neck of the fibula. The motor component of deep peroneal nerve is responsible for innervating the anterior compartment of the lower leg which includes the tibialis anterior, extensor hallucis longus, extensor digitorum longus, and peroneus tertius muscles.

Read more

Nerve conduction velocity shortly known as "NCV" tests are used determine the speed of the electrical signals moving along a specific peripheral nerve .This will be helpful in localizing the site of entrapment of peripheral nerves and useful for assessing both recovery and prognosis of any injury to peripheral nervesthere are numerous aspects that could influence nerve conduction study.

Although changes in joint position have been reported in several studies to affect nerve conduction velocity of peripheral nerves. the effect of changing ankle joint position on deep peroneal NCV has not been repor Purpose

This study will investigate the effect of different ankle positions on:

  1. Deep peroneal nerve distal motor latency across ankle joint.
  2. Deep peroneal nerve sensory onset latency across ankle joint
Read the detailed description

31healthy subjects of both genders with age ranging from 20to 40years old were examined for motor distal latency and sensory onset latency at three different ankle positions :neutral,20degrees dorsiflexion and 40degrees plantar flexion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Deep peroneal nerve motor distal latency

    Motor distal latency: It is the time between the distal stimulus and the onset of compound muscle action potential(CMAP)at recording muscles

    Measured: 30 minutes for each participant

  2. Deep peroneal nerve sensory onset latency

    : It is the time taken from the stimulus artifact to the initial negative deflection of the sensory nerve action potential (SNAP)

    Measured: 30 minutes for each participant

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2022
  2. Study start5 Dec 2022
  3. Primary completion3 Jan 2023
  4. Study completion26 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05635721
Sponsor's protocol ID
P.T.REC/012/004076
Status last verified
Jan 2023
First submitted
23 Nov 2022
Last updated
30 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Subjects, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Deep peroneal nerve motor distal latency (time frame: 30 minutes for each participant). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in